×

CLIN RADIOL 2020 10.1016/j.crad.2020.01.002
Targetoid hepatic observations on gadoxetic acid-enhanced MRI using LI-RADS version 2018: emphasis on hepatocellular carcinomas assigned to the LR-M category
Park1, HJ; Kim, YK; Cha, DI; Ko, SE; Kim, S; Lee, ES; Ahn, S

RADIOLOGY 2020 10.1148/radiol.2020190639
Use of Gadoxetic Acid enhanced Liver MRI and Morality in More than 30000 Patients with Hepatocellular Carcinoma: A Nationwide Analysis
Kang1, TW; Kong, SY; Kang, D; Kang, MW; Kim, YK; Kim, SH; Sinn, DH; Kim, YA; Choi, KS; Lee, ES; Cho, J; Guallar, E; Back, JH; Woo, SM

KOREAN J RADIOL 2020 10.3348/kjr.2019.0538
Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients
Cha1, DI; Jang, KM; Kim, SH; Kim, YK; Kim, H; Ahn, SH

CLIN RADIOL 2020 10.1016/j.crad.2019.11.004
Comparison of the diagnostic performance of the 2017 and 2018 versions of LI-RADS for hepatocellular carcinoma on gadoxetic acid enhanced MRI
Ko1, A; Park, HJ; Lee, ES; Park, SB; Kim, YK; Choi, SY; Ahn, S

EUR RADIOL 2020 10.1007/s00330-020-06753-5
Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS
Cha1, DI; Choi, GS; Kim, YK; Kim, JM; Kang, TW; Song, KD; Ahn, SH

Abdom Radiol (NY) 2019 10.1007/s00261-019-02068-2
Differentiation of hypervascular primary hepatic tumors showing hepatobiliary hypointensity on gadoxetic acid-enhanced magnetic resonance imaging
Park1, HJ; Kim, YK; Min, JH; Lee, J; Lee, SJ; Lee, ES; Ahn, S

ACTA RADIOL 2019 10.1177/0284185118805253
Evaluation of early treatment response to radiotherapy for HCC using pre- and post-treatment MRI
Song1, SH; Jeong, WK; Choi, D; Kim, YK; Park, HC; Yu, JI

Abdom Radiol (NY) 2019 10.1007/s00261-019-01968-7
Diagnosis of recurrent HCC: intraindividual comparison of gadoxetic acid MRI and extracellular contrast-enhanced MRI
Yim1, JH; Kim, YK; Min, JH; Lee, J; Kang, TW; Lee, SJ

MEDICINE 2019 10.1097/MD.0000000000015867
Semiautomatic software for measurement of abdominal muscle and adipose areas using computed tomography A STROBE-compliant article
Kim1, SS; Kim, JH; Jeong, WK; Lee, J; Kim, YK; Choi, D; Lee, WJ

CLIN IMAG 2019 10.1016/j.clinimag.2019.02.013
Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis
Lee1, JH; Min, JH; Kim, YK; Cha, DI; Lee, J; Park, HJ; Ahn, S

ACTA RADIOL 2019 10.1177/0284185118788901
Non-contrast liver MRI as an alternative to gadoxetic acid-enhanced MRI for liver metastasis from colorectal cancer
Hwang1, JA; Kim, YK; Min, JH; Song, KD; Sohn, I; Ahn, HS

Abdom Radiol (NY) 2019 10.1007/s00261-018-1847-y
Differentiation between inflammatory myofibroblastic tumor and cholangiocarcinoma manifesting as target appearance on gadoxetic acid-enhanced MRI
Chang1, AI; Kim, YK; Min, JH; Lee, J; Kim, H; Lee, SJ

EUR RADIOL 2019 10.1007/s00330-018-5771-x
Intra-individual comparison of gadolinium-enhanced MRI using pseudo-golden-angle radial acquisition with gadoxetic acid-enhanced MRI for diagnosis of HCCs using LI-RADS
Kim1, YC; Min, JH; Kim, YK; Lee, SJ; Ahn, S; Kim, E; Peeters, H

CLIN IMAG 2019 10.1016/j.clinimag.2018.12.001
Usefulness of noncontrast MRI in differentiation between gallbladder carcinoma and benign conditions manifesting as focal mild wall thickening
Cha1, SY; Kim, YK; Min, JH; Lee, J; Cha, DI; Lee, SJ

RADIOLOGY 2019 10.1118/radiol.2018181485
Intrahepatic Mass-formimg Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis
Min1, JH; Kim, YK; Choi, SY; Kang, TW; Lee, SJ; Kim, JM; Ahn, S; Cho, H

KOREAN J RADIOL 2019 10.3348/kjr.2018.0339
Identification of Arterial Hyperenhancement in CT and MRI in Patients with Hepatocellular Carcinoma: Value of Unenhanced Images
Kim1, M; Kang, TW; Cha, DI; Jang, KM; Kim, YK; Kim, SH; Sinn, DH; Kim, K

HEPATOLOGY 2018 10.1002/hep.30122
Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System
Min1, JH; Kim, JM; Kim, YK; Kang, TW; Lee, SJ; Choi, GS; Choi, SY; Ahn, S

Abdom Radiol (NY) 2018 10.1007/s00261-018-1653-6
Hepatic neuroendocrine tumors: gadoxetic acid-enhanced magnetic resonance imaging findings with an emphasis on differentiation between primary and secondary tumors
Cha1, DI; Kang, TW; Jang, KM; Kim, YK; Kim, SH; Ha, SY; Sohn, I

BRIT J RADIOL 2018 10.1259/bjr.20180177
Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging
Min1, JH; Kim, YK; Choi, SY; Kang, TW; Jeong, WK; Kim, K; Won, HJ

Abdom Radiol (NY) 2018 10.1007/s00261-018-1480-9
Adding ancillary features to enhancement patterns of hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging improves diagnostic performance
Min1, JH; Kim, YK; Sinn, DH; Choi, SY; Jeong, WK; Lee, WJ; Ha, SY; Ahn, S; Kim, MJ

EUR RADIOL 2018 10.1007/s00330-018-5307-4
Artifacts during the arterial phase of gadoxetate disodium-enhanced MRI: Multiple arterial phases using view-sharing from two different vendors versus single arterial phase imaging
Min1, JH; Kim, YK; Kang, TW; Jeong, WK; Lee, WJ; Ahn, S; Hwang, NY

EUR RADIOL 2018 10.1007/s00330-017-5248-3
Hepatic neuroendocrine tumour: Apparent diffusion coefficient as a potential marker of prognosis associated with tumour grade and overall survival
Min1, JH; Kang, TW; Kim, YK; Kim, SH; Shin, KS; Lee, JE; Ha, SY; Sohn, I

J HEPATOL 2018 10.1016/j.jhep.2018.01.024
Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma
Kim1, AY; Sinn, DH; Jeong, WK; Kim, YK; Kang, TW; Ha, SY; Park, CK; Choi, GS; Kim, JM; Kwon, CHD; Joh, JW; Kim, MJ; Sohn, I; Jung, SH; Paik, SW; Lee, WJ

EUR RADIOL 2018 10.1007/s00330-017-5196-y
Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging
Choi1, SY; Kim, YK; Min, JH; Kang, TW; Jeong, WK; Ahn, S; Won, H

ACTA RADIOL 2018 10.1177/0284185117728534
Intra-individual comparison of hepatocellular carcinoma imaging computed tomconstrast-enhancedtte computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI
Kim1, YN; Song, JS; Moon, WS; Hwang, HP; Kim, YK

CLIN RADIOL 2018 10.1016/j.crad.2018.01.016
Prediction and clinical implications of portal vein/superior mesenteric vein invasion in patients with resected pancreatic head cancer: the significance of preoperative CT parameters
Kim1, M; Kang, TW; Cha, DI; Kim, YK; Kim, SH; Jang, KT; Han, IW; Sohn, I

ACTA RADIOL 2018 10.1177/0284185117723040
Hepatocellular carcinoma with central scar on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance imaging
Han1, SB; Kim, YK; Min, JH; Ha, SY; Jeong, WK; Lee, WJ

EUR RADIOL 2018 10.1007/s00330-017-4926-5
Comparison between MRI with MR cholangiopancreatography and endoscopic ultrasonography for differentiating malignant from benign mucinous neoplasms of the pancreas
Hwang1, J; Kim, YK; Min, JH; Jeong, WK; Hong, SS; Kim, HJ

CLIN IMAG 2018 10.1016/j.clinimag.2017.08.004
The qualitative and quantitative image analysis of MR imaging in patients with acute-on-chronic liver failure
Kang1, TW; Kim, M; Kim, YK; Kim, SH; Sinn, DH; Kim, K
외 다수